Status:
COMPLETED
Cutaneous Leishmaniasis Diagnostic Study
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Conditions:
Cutaneous Leishmaniases
Eligibility:
All Genders
2+ years
Brief Summary
The performance of the CL Detect Rapid test will be tested in individuals with suspected cutaneous leishmaniasis in Ethiopia using both skin slit and dental broach samples against a combined reference...
Detailed Description
Cutaneous Leishmaniasis is common in Ethiopia and mainly affects the poor living in rural areas. Diagnosis of CL routinely uses invasive skin slits which are examined with microscopy, requiring traine...
Eligibility Criteria
Inclusion
- \- Clinical suspicion of CL
Exclusion
- ≤ 2 years of age
- Not willing or able to provide consent/assent
- CL presentation with only lesions for which skin slit samples cannot be obtained (e.g. eyelids)
- Co-morbidity with visceral leishmaniasis
- On CL treatment at time of enrollment
Key Trial Info
Start Date :
February 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT03837431
Start Date
February 13 2019
End Date
January 31 2023
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leishmania Research and Treatment Center, University of Gondar hospital
Gonder, Ethiopia